Abstract:The fibroblast growth factor (FGF) family consists of 22 members and regulates a broad spectrum of biological activities by activating diverse isotypes of FGF receptor tyrosine kinases (FGFRs). Among the FGFs, FGF7 and FGF10 have been implicated in the regulation of prostate development and prostate tissue homeostasis by signaling through the FGFR2 isoform. Using conditional gene ablation with the Cre-LoxP system in mice, we demonstrate a tissue-specific requirement for FGFR2 in urogenital epithelial cells - the precursors of prostatic epithelial cells - for prostatic branching morphogenesis and prostatic growth. Most Fgfr2 conditional null (Fgfr2cn) embryos developed only two dorsal prostatic (dp) and two lateral prostatic (lp) lobes. This contrasts to wild-type prostate, which has two anterior prostatic (ap), two dp, two lp and two ventral prostatic (vp) lobes. Unlike wild-type prostates, which are composed of well developed epithelial ductal networks, the Fgfr2cn prostates, despite retaining a compartmented tissue structure, exhibited a primitive epithelial architecture. Moreover, although Fgfr2cn prostates continued to produce secretory proteins in an androgen-dependent manner, they responded poorly to androgen with respect to tissue homeostasis. The results demonstrate that FGFR2 is important for prostate organogenesis and for the prostate to develop into a strictly androgen-dependent organ with respect to tissue homeostasis but not to the secretory function, implying that androgens may regulate tissue homeostasis and tissue function differently. Therefore, Fgfr2cn prostates provide a useful animal model for scrutinizing molecular mechanisms by which androgens regulate prostate growth, homeostasis and function, and may yield clues as to how advanced-tumor prostate cells escape strict androgen regulations.

Tumor and Stem Cell Biology FGFR 1 Is Essential for Prostate Cancer Progression and Metastasis

FGFR1 is Essential for Prostate Cancer Progression and Metastasis

Supplementary Figure 2 from FGFR1 is Essential for Prostate Cancer Progression and Metastasis

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer

Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells

A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis.

Fibroblast Growth Factor Receptor 2 Tyrosine Kinase is Required for Prostatic Morphogenesis and the Acquisition of Strict Androgen Dependency for Adult Tissue Homeostasis

Role of Epithelial Cell Fibroblast Growth Factor Receptor Substrate 2 Alpha in Prostate Development, Regeneration and Tumorigenesis

Fibroblast Growth Factor Receptor 1 Phosphotyrosine 766: Molecular Target For Prevention Of Progression Of Prostate Tumors To Malignancy

Supplementary Figure 3 from FGFR1 is Essential for Prostate Cancer Progression and Metastasis

Supplementary Figure 4 from FGFR1 is Essential for Prostate Cancer Progression and Metastasis

Data from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Chronic Activity of Ectopic Type 1 Fibroblast Growth Factor Receptor Tyrosine Kinase in Prostate Epithelium Results in Hyperplasia Accompanied by Intraepithelial Neoplasia

The FGF/FGFR system in the physiopathology of the prostate gland

Loss of TGF-β Signaling in Osteoblasts Increases Basic-Fgf and Promotes Prostate Cancer Bone Metastasis.

Tumors to Malignancy Molecular Target for Prevention of Progression of Prostate Fibroblast Growth Factor Receptor 1 Phosphotyrosine 766 : Updated

Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells

FGFR1 governs iron metabolism via regulating post-translational modification of IRP2 in prostate cancer cells

Overexpression of FGF9 in Prostate Epithelial Cells Augments Reactive Stroma Formation and Promotes Prostate Cancer Progression

FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells

EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis